UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective decreased by investment analysts at KeyCorp from $650.00 to $575.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an "overweight" rating on the healthcare conglomerate's stock. KeyCorp's target price suggests a potential upside of 35.39% from the stock's current price.
Other equities analysts have also issued reports about the stock. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Mizuho lifted their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday. Erste Group Bank upgraded UnitedHealth Group to a "strong-buy" rating in a research note on Wednesday, April 16th. Finally, HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $603.05.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Trading Down 0.8 %
Shares of UnitedHealth Group stock traded down $3.26 during trading on Monday, hitting $424.70. 7,608,478 shares of the company were exchanged, compared to its average volume of 4,455,390. The firm's fifty day moving average price is $506.92 and its 200 day moving average price is $537.23. UnitedHealth Group has a 1-year low of $417.12 and a 1-year high of $630.73. The firm has a market capitalization of $388.48 billion, a P/E ratio of 27.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.
Institutional Investors Weigh In On UnitedHealth Group
Hedge funds have recently added to or reduced their stakes in the business. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $28,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.